General Information of Drug (ID: DMPMO6G)

Drug Name
CC-401 Drug Info
Synonyms
CC-401; 395104-30-0; UNII-NOE38VQA1W; NOE38VQA1W; 3-(3-(2-(piperidin-1-yl)ethoxy)phenyl)-5-(1H-1,2,4-triazol-5-yl)-1H-indazole; 3-(3-(2-(piperidin-1-yl)ethoxy)phenyl)-5-(1H-1,2,4-triazol-3-yl)-1H-indazole; 3-[3-[2-(1-PIPERIDINYL)ETHOXY]PHENYL]-5-(1H-1,2,4-TRIAZOL-5-YL)-1H-INDAZOLE; CC 401; C22H24N6O; PubChem22434; SCHEMBL4604749; CHEMBL1614713; CHEBI:91437; DTXSID40192650; MolPort-044-561-531; MolPort-021-804-942; BCPP000298; BCP01960; ZINC38836256; RS0046; HY-13022A; AKOS027251057; AKOS027336636; DB12432; BCP9000495; CS-1955
Therapeutic ClassAnticancer Agents
Cross-matching ID
PubChem CID
10430360
ChEBI ID
CHEMBL1614713
CAS Number
CAS 395104-30-0
TTD Drug ID
D04UUD

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Cell cycle 2.36 0.00e+0 110/124 (88.71%) CCNB2;PLK1;CDC20;...
Oocyte meiosis 2.09 0.00e+0 90/129 (69.77%) CCNB2;PLK1;CDC20;...
DNA replication 2.03 0.00e+0 34/36 (94.44%) POLE3;POLE2;RFC3;...
Progesterone-mediated oocyte maturation 1.96 0.00e+0 75/100 (75%) CCNB2;PLK1;CCNA2;...
Fanconi anemia pathway 1.89 9.83e-3 36/54 (66.67%) RPA3;USP1;RAD51;...
mRNA surveillance pathway 1.88 9.83e-3 71/98 (72.45%) RNPS1;FUS;DAZAP1;...
Fat digestion and absorption 1.82 1.68e-2 35/43 (81.4%) APOA1;APOB;PNLIPRP2;...
Nucleotide excision repair 1.81 1.47e-2 40/47 (85.11%) POLE3;POLE2;DDB2;...
RNA transport 1.78 2.07e-2 128/186 (68.82%) EIF1AY;TACC3;EIF4E;...
Endometrial cancer 1.77 1.97e-2 56/58 (96.55%) PDPK1;DDB2;HRAS;...
Ribosome 1.75 1.97e-2 113/158 (71.52%) RPS4Y1;RPS5;MRPS16;...
RNA degradation 1.70 3.52e-2 53/79 (67.09%) C1D;TENT4A;ENO3;...
Ribosome biogenesis in eukaryotes 1.69 3.63e-2 52/108 (48.15%) DKC1;GTPBP4;POP4;...
Spliceosome 1.68 3.79e-2 101/150 (67.33%) FUS;SNRPA1;PRPF4;...
Base excision repair 1.66 4.00e-2 29/33 (87.88%) POLE3;POLE2;HMGB1;...
Human immunodeficiency virus 1 infection 1.65 4.18e-2 189/212 (89.15%) CCNB2;TLR4;GNA11;...
Thyroid cancer 1.62 4.91e-2 36/37 (97.3%) DDB2;HRAS;KRAS;...
RNA polymerase 1.60 5.00e-2 23/31 (74.19%) POLR2D;POLR2L;POLR2C;...
Long-term potentiation 1.60 4.79e-2 61/67 (91.04%) PRKCB;HRAS;ADCY1;...
Propanoate metabolism -1.67 4.80e-2 30/34 (88.24%) SUCLG1;ACADS;BCKDHB;...
Metabolism of xenobiotics by cytochrome P450 -1.70 3.55e-2 49/77 (63.64%) GSTA1;GSTM1;GSTP1;...
Lysosome -1.71 3.67e-2 115/128 (89.84%) CTSB;CTSD;ABCA2;...
Fructose and mannose metabolism -1.72 3.47e-2 30/33 (90.91%) HK2;GMDS;FBP1;...
Rheumatoid arthritis -1.73 3.14e-2 78/93 (83.87%) ITGB2;IL23A;ATP6V1D;...
Sulfur metabolism -1.74 3.45e-2 9/10 (90%) SUOX;MPST;SQOR;...
Mucin type O-glycan biosynthesis -1.74 3.83e-2 20/36 (55.56%) GCNT3;ST6GALNAC4;B3GNT3;...
IL-17 signaling pathway -1.75 3.93e-2 84/94 (89.36%) TRAF3IP2;NFKBIA;TRAF5;...
Citrate cycle (TCA cycle) -1.76 3.91e-2 30/30 (100%) SDHA;PDHA1;ACLY;...
ABC transporters -1.78 3.21e-2 37/45 (82.22%) ABCC4;ABCB7;DEFB1;...
Peroxisome -1.79 3.04e-2 72/82 (87.8%) ACOX1;PHYH;MLYCD;...
Tyrosine metabolism -1.80 3.04e-2 30/36 (83.33%) MAOA;PNMT;ADH7;...
Other types of O-glycan biosynthesis -1.86 2.03e-2 29/47 (61.7%) MFNG;GALNT7;OGT;...
Valine, leucine and isoleucine degradation -1.88 2.54e-2 42/48 (87.5%) ACADS;BCKDHB;AACS;...
Other glycan degradation -2.07 0.00e+0 13/18 (72.22%) GLB1;NEU1;ENGASE;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone marrow
Neuroblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SH-SY5Y CVCL_0019 Homo sapiens 0.04uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 6H, 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
Normal (Epithelial)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HME1 CVCL_2950 Homo sapiens 0.04uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 0.04uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.04uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 6H, 24H
A549/Asc-1 CVCL_YA87 Homo sapiens 0.04uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 0.04uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 6H, 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 6H, 24H
SK-L CVCL_1699 Homo sapiens 0.04uM - 10uM 24H
Umbilical vein
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HUVEC-C CVCL_2959 Homo sapiens 0.04uM - 10uM 24H